Edition:
India

Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

80.41USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$80.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,382,044
52-wk High
$89.71
52-wk Low
$76.52

Latest Key Developments (Source: Significant Developments)

Medtronic Receives FDA Clearance For Riptide Aspiration System
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - Medtronic Plc ::MEDTRONIC RECEIVES FDA CLEARANCE FOR RIPTIDE(TM) ASPIRATION SYSTEM.MEDTRONIC SAYS UNIT RECEIVED U.S. FDA CLEARANCE OF RIPTIDE ASPIRATION SYSTEM.  Full Article

FDA Approves Innovative Clinician Programmer For The Medtronic Synchromed II Intrathecal Drug Delivery System
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Medtronic Plc ::FDA APPROVES INNOVATIVE CLINICIAN PROGRAMMER FOR THE MEDTRONIC SYNCHROMED II INTRATHECAL DRUG DELIVERY SYSTEM FOR CHRONIC PAIN AND SEVERE SPASTICITY.  Full Article

Medtronic reports Q2 non-GAAP earnings per share of $1.07
Tuesday, 21 Nov 2017 

Nov 21 (Reuters) - Medtronic Plc :Medtronic reports second quarter financial results.Q2 non-GAAP earnings per share $1.07.Q2 GAAP earnings per share $1.48.Q2 earnings per share view $0.98 -- Thomson Reuters I/B/E/S.Medtronic Plc - ‍company reiterates full year revenue and EPS guidance​.Medtronic Plc - qtrly ‍revenue of $7.1 billion​.Q2 revenue view $6.93 billion -- Thomson Reuters I/B/E/S.Medtronic plc qtrly ‍CVG worldwide revenue of $2.773 billion increased 7 percent on both a reported and constant currency basis​.Medtronic plc qtrly ‍RTG worldwide revenue of $1.863 billion increased 2 percent on both a reported and constant currency basis​.FY2018 earnings per share view $4.68, revenue view $29.36 billion -- Thomson Reuters I/B/E/S.Medtronic Plc qtrly ‍spine revenue of $659 million decreased 1 percent on both a reported and constant currency basis​.Medtronic Plc - ‍in fiscal year 2018, company continues to expect comparable, constant currency revenue growth to be in range of 4 to 5 percent​.Medtronic Plc - "‍Hurricane Maria, in particular, significantly affected our manufacturing operations in Puerto Rico"​ for quarter.  Full Article

Medtronic announces FDA approval and U.S. launch of next generation pacemakers
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Medtronic Plc :Medtronic announces FDA approval and U.S. launch of next generation pacemakers.Medtronic Plc - announces ‍U.S. FDA approval and U.S. commercial launch of portfolio of Azure pacemakers with Bluesync technology​.  Full Article

Medtronic ‍reiterates Q2 EPS expectations excluding Hurricane Maria impact​
Thursday, 9 Nov 2017 

Nov 8 (Reuters) - Medtronic Plc :Medtronic announces preliminary second quarter revenue.Medtronic PLC - ‍reiterates Q2 EPS expectations excluding Hurricane Maria impact​.Medtronic PLC - ‍preliminary Q2 revenue of approximately $7.1 billion​.Medtronic PLC - ‍company announced that impact of hurricane maria was approximately $55 to $65 million to its q2 revenue​.Medtronic - preliminary ‍Q2 revenue increased 3 percent on comparable, constant currency basis.Medtronic PLC - ‍impact of hurricane maria expected to be approximately $0.03 to its q2 non-gaap earnings per share​.Medtronic - ‍excluding impact of hurricane maria, prelim. Q2 revenue growth would have been 4 percent on comparable, constant currency basis​.Medtronic PLC - expects a one cent positive impact to Q2 adjusted EPS from foreign currency​.Q2 earnings per share view $0.94, revenue view $6.87 billion -- Thomson Reuters I/B/E/S.  Full Article

Medtronic Endurant II/IIs stent graft system receives FDA approval to treat short neck anatomies
Monday, 9 Oct 2017 

Oct 9 (Reuters) - Medtronic Plc :Medtronic Endurant II/IIs stent graft system receives FDA approval to treat short neck anatomies when used with Heli-FX EndoAnchor system.Medtronic - ‍expanded indication enables Endurant II/IIs stent graft to be used in conjunction with Heli-FX EndoAnchor system.  Full Article

Medtronic provides update on impact from hurricane Maria
Saturday, 7 Oct 2017 

Oct 6 (Reuters) - Medtronic Plc :Medtronic provides update on impact from hurricane Maria.Medtronic Plc - ‍estimates an impact to both revenue and non-gaap net earnings up to $250 million dollars in fiscal 2018 Q2​.Says ‍company reaffirms its fiscal 2018 Q2 and full fiscal year guidance provided on August 22, 2017​.Medtronic Plc - ‍excluding expected impact of hurricane Maria, company reaffirms its fiscal 2018 Q2 and full fiscal year guidance provided on August 22​.Medtronic Plc - ‍considering severity of hurricane, company's puerto rico facilities fared well, but each sustained some damage​.Medtronic Plc - ‍continues to expect mid-single digit revenue growth on a comparable, constant currency basis in second half of fiscal year​.Medtronic Plc - has made considerable progress in repairing puerto rico manufacturing facilities, with limited production starting on October 2​.Medtronic plc - expects some non-recurring expenses directly related to recovery efforts in puerto rico to be excluded from its 2018 non-GAAP earnings.Medtronic - all of sites are partially operating, manufacturing is expected to gradually ramp up over coming weeks​.Medtronic Plc - ‍is utilizing existing inventory levels and increasing manufacturing in locations outside of Puerto Rico for many of its products​.  Full Article

Medtronic reaffirms guidance, provides update on hurricane Maria impact
Saturday, 7 Oct 2017 

Oct 6 (Reuters) - Medtronic Plc ::Medtronic provides update on impact from hurricane Maria.Says ‍excluding expected impact of hurricane Maria,‍ co reaffirms fiscal 2018 q2 and full fiscal year guidance provided on august 22, 2017​.Fy2018 earnings per share view $4.77, revenue view $29.47 billion -- Thomson Reuters I/B/E/S.Q2 earnings per share view $1.07, revenue view $7.08 billion -- Thomson Reuters I/B/E/S.Is utilizing existing inventory levels and increasing manufacturing in locations outside of Puerto Rico for many of its products​.Estimates an impact to both revenue and non-gaap net earnings up to $250 million dollars in fiscal 2018 q2​.Excluding expected impact of hurricane Maria, company reaffirms its fiscal 2018 q2 and full fiscal year guidance provided on august 22​.Considering severity of hurricane, company's Puerto Rico facilities fared well, but each sustained some damage​.Continues to expect mid-single digit revenue growth on a comparable, constant currency basis in second half of fiscal year​.Has made considerable progress in repairing Puerto Rico manufacturing facilities, with limited production starting on october 2​.Expects some non-recurring expenses directly related to recovery efforts in puerto rico to be excluded from its q2 2018 non-gaap earnings.All of sites are partially operating, manufacturing is expected to gradually ramp up over coming weeks​.  Full Article

New five-year gender subset data from the Medtronic engage registry presented in viva late breaking trials
Wednesday, 13 Sep 2017 

Sept 13 (Reuters) - Medtronic Plc :New five-year gender subset data from the medtronic engage registry presented in viva late breaking trials.Says ‍endurant ii aaa stent graft system continues to demonstrate "long-term durability and consistent" outcomes in among both male, female patients​.  Full Article

Medtronic expects diabetes group to grow in the range of 1 pct to 4 pct this fiscal year
Tuesday, 22 Aug 2017 

Aug 22 (Reuters) - Medtronic Plc :Medtronic CFO says "expects diabetes group to grow in the range of 1 percent to 4 percent this fiscal year" - Conf Call.Medtronic expects minimally invasive therapies group to grow in the range of 3.5 percent to 4.5 percent this fiscal year - Conf Call.  Full Article

Medtronic quarterly revenue beats, margins disappoint

Medical device maker Medtronic Plc's quarterly revenue beat analysts' expectations as new product launches drove sales across its business units, but weaker-than-expected margins clouded the earnings report.